372 related articles for article (PubMed ID: 22334251)
1. Colonic transit time and IBS symptoms: what's the link?
Törnblom H; Van Oudenhove L; Sadik R; Abrahamsson H; Tack J; Simrén M
Am J Gastroenterol; 2012 May; 107(5):754-60. PubMed ID: 22334251
[TBL] [Abstract][Full Text] [Related]
2. Different segmental transit times in patients with irritable bowel syndrome and "normal" colonic transit time: is there a correlation with symptoms?
Bouchoucha M; Devroede G; Dorval E; Faye A; Arhan P; Arsac M
Tech Coloproctol; 2006 Dec; 10(4):287-96. PubMed ID: 17115321
[TBL] [Abstract][Full Text] [Related]
3. Stool characteristics and colonic transit in irritable bowel syndrome: evaluation at two time points.
Shim L; Talley NJ; Boyce P; Tennant C; Jones M; Kellow JE
Scand J Gastroenterol; 2013 Mar; 48(3):295-301. PubMed ID: 23320464
[TBL] [Abstract][Full Text] [Related]
4. Bloating and distension in irritable bowel syndrome: the role of gastrointestinal transit.
Agrawal A; Houghton LA; Reilly B; Morris J; Whorwell PJ
Am J Gastroenterol; 2009 Aug; 104(8):1998-2004. PubMed ID: 19491831
[TBL] [Abstract][Full Text] [Related]
5. Effect of tegaserod on colonic transit time in male patients with constipation-predominant irritable bowel syndrome.
Harish K; Hazeena K; Thomas V; Kumar S; Jose T; Narayanan P
J Gastroenterol Hepatol; 2007 Aug; 22(8):1183-9. PubMed ID: 17688659
[TBL] [Abstract][Full Text] [Related]
6. Faecal retention: a common cause in functional bowel disorders, appendicitis and haemorrhoids--with medical and surgical therapy.
Raahave D
Dan Med J; 2015 Mar; 62(3):. PubMed ID: 25748875
[TBL] [Abstract][Full Text] [Related]
7. Correlation of bowel symptoms with colonic transit, length, and faecal load in functional faecal retention.
Raahave D; Christensen E; Loud FB; Knudsen LL
Dan Med Bull; 2009 May; 56(2):83-8. PubMed ID: 19486620
[TBL] [Abstract][Full Text] [Related]
8. Subtyping the irritable bowel syndrome by predominant bowel habit: Rome II versus Rome III.
Ersryd A; Posserud I; Abrahamsson H; Simrén M
Aliment Pharmacol Ther; 2007 Sep; 26(6):953-61. PubMed ID: 17767480
[TBL] [Abstract][Full Text] [Related]
9. Characterization of episodes of irritable bowel syndrome using ecological momentary assessment.
Weinland SR; Morris CB; Hu Y; Leserman J; Bangdiwala SI; Drossman DA
Am J Gastroenterol; 2011 Oct; 106(10):1813-20. PubMed ID: 21647206
[TBL] [Abstract][Full Text] [Related]
10. Importance of diarrhea in evaluating constipation in irritable bowel syndrome clinical studies.
Basseri RJ; Kunkel D; Low K; Conklin JL; Pimentel M
J Clin Gastroenterol; 2011 Oct; 45(9):790-3. PubMed ID: 21301356
[TBL] [Abstract][Full Text] [Related]
11. Gastrointestinal-specific anxiety: an important factor for severity of GI symptoms and quality of life in IBS.
Jerndal P; Ringström G; Agerforz P; Karpefors M; Akkermans LM; Bayati A; Simrén M
Neurogastroenterol Motil; 2010 Jun; 22(6):646-e179. PubMed ID: 20367800
[TBL] [Abstract][Full Text] [Related]
12. Short-term stability of subtypes in the irritable bowel syndrome: prospective evaluation using the Rome III classification.
Engsbro AL; Simren M; Bytzer P
Aliment Pharmacol Ther; 2012 Feb; 35(3):350-9. PubMed ID: 22176384
[TBL] [Abstract][Full Text] [Related]
13. Patients suspected of irritable bowel syndrome--cross-sectional study exploring the sensitivity of Rome III criteria in primary care.
Engsbro AL; Begtrup LM; Kjeldsen J; Larsen PV; de Muckadell OS; Jarbøl DE; Bytzer P
Am J Gastroenterol; 2013 Jun; 108(6):972-80. PubMed ID: 23419383
[TBL] [Abstract][Full Text] [Related]
14. Relationship of abdominal bloating to distention in irritable bowel syndrome and effect of bowel habit.
Houghton LA; Lea R; Agrawal A; Reilly B; Whorwell PJ
Gastroenterology; 2006 Oct; 131(4):1003-10. PubMed ID: 17030170
[TBL] [Abstract][Full Text] [Related]
15. Rome III functional constipation and irritable bowel syndrome with constipation are similar disorders within a spectrum of sensitization, regulated by serotonin.
Shekhar C; Monaghan PJ; Morris J; Issa B; Whorwell PJ; Keevil B; Houghton LA
Gastroenterology; 2013 Oct; 145(4):749-57; quiz e13-4. PubMed ID: 23872499
[TBL] [Abstract][Full Text] [Related]
16. Irritable bowel syndrome: a population based study.
Khoshkrood-Mansoori B; Pourhoseingholi MA; Safaee A; Moghimi-Dehkordi B; Sedigh-Tonekaboni B; Pourhoseingholi A; Habibi M; Zali MR
J Gastrointestin Liver Dis; 2009 Dec; 18(4):413-8. PubMed ID: 20076812
[TBL] [Abstract][Full Text] [Related]
17. Outcome of biofeedback therapy in dyssynergic defecation patients with and without irritable bowel syndrome.
Patcharatrakul T; Gonlachanvit S
J Clin Gastroenterol; 2011 Aug; 45(7):593-8. PubMed ID: 21346602
[TBL] [Abstract][Full Text] [Related]
18. Differences in gastrointestinal symptoms according to gender in Rome II positive IBS and dyspepsia in a Latin American population.
Schmulson M; Adeyemo M; Gutiérrez-Reyes G; Charúa-Guindic L; Farfán-Labonne B; Ostrosky-Solis F; Díaz-Anzaldúa A; Medina L; Chang L
Am J Gastroenterol; 2010 Apr; 105(4):925-32. PubMed ID: 20179693
[TBL] [Abstract][Full Text] [Related]
19. Altered levels of fecal chromogranins and secretogranins in IBS: relevance for pathophysiology and symptoms?
Ohman L; Stridsberg M; Isaksson S; Jerlstad P; Simrén M
Am J Gastroenterol; 2012 Mar; 107(3):440-7. PubMed ID: 22233694
[TBL] [Abstract][Full Text] [Related]
20. Cumulative Effects of Psychologic Distress, Visceral Hypersensitivity, and Abnormal Transit on Patient-reported Outcomes in Irritable Bowel Syndrome.
Simrén M; Törnblom H; Palsson OS; Van Oudenhove L; Whitehead WE; Tack J
Gastroenterology; 2019 Aug; 157(2):391-402.e2. PubMed ID: 31022401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
